ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

ACS Announces New Awards for Nurses

October 30, 1987

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

July 13, 2007

Two New Organ Systems Working Groups to Be Considered By NCAB

October 4, 1985

In Brief: Howard Skipper Retires; Oglesby To Head SRI; John Montgomery Named Kettering-Meyer Director

December 19, 1980

NINDS Awards Grants For Brain Tumor Centers

December 11, 1992